GEOCLOCK
DEAD

Serial Number

77027863

Owner

JAGOTEC AG

Attorney

Peter J. Riebling

Filing Date

Oct 24, 2006

Add to watchlist:

No watchlists yet
View on USPTO

GEOCLOCK Trademark

Serial Number: 77027863 • Registration: 4133487

GEOCLOCK is a trademark filed by JAGOTEC AG on October 24, 2006. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

JAGOTEC AG (32 trademarks)

POSTFACH 244
HERGISWIL NW , CH

Entity Type: 03

Trademark Details

Filing Date

October 24, 2006

Registration Date

May 1, 2012

Published for Opposition

December 29, 2009

Cancellation Date

December 7, 2018

Goods & Services

Pharmaceuticals having a time release effect used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; pharmaceutical and veterinary preparations used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; preparations for medical, surgical and biological purposes for the treatment of diseases of the nervous system, sleep disorders and arthritis; dietetic foods containing pharmaceutically active substances adapted for medical or veterinary use; beverages, solutions and foods for the purpose of providing a time release effect, for use in the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; chronotherapy-focused press coated tablets, analgesics; bacterial preparations for medical and veterinary purposes; chemical reagents for medical and veterinary purposes; diagnostic reagents for medical use; chemical reagents and chemical preparations for pharmaceutical use in the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; medicinal and veterinary oils used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; diagnostic preparations for medical and veterinary purposes; medicines and medicinal preparations used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; tablets for the release of colonic drug delivery; drugs for the treatment of sleep disorders; medical and veterinary preparations for slimming purposes; ointments, creams and powders for medical and veterinary purposes used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; capsules, suppositories, tablets and pills for pharmaceutical, medical and veterinary purposes used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; pre-filled instruments and apparatus for the administration of time release therapy and prophylaxis preparations and substances, namely, vials, inhalers, syringes, needles and injectors used for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology; medical, veterinary and surgical apparatus, instruments and devices, namely, pre-filled vials, syringes and injectors for medical purposes for the treatment of diseases and disorders of the central nervous system, cardiovascular system, respiratory system, genitor-unitary system, renal system, gastro-intestinal system, eye, hepatic system, vascular system, immune system, neurological disorders, hormonal and endocrinology disorders, musculoskeletal and inflammatory disorders, neuromuscular disorders and for use in oncology and hematology

Inhalers for medical purposes, and medical and veterinary syringes and needles; catheters; syringes and injectors for medical purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 7, 2018 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 1, 2017 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 15, 2016 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 10, 2016 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 4, 2016 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 4, 2016 TCCA
REGISTERED-PRINCIPAL REGISTER
May 1, 2012 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Mar 27, 2012 DP1B
NOTICE OF ALLOWANCE CANCELLED
Mar 23, 2012 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Mar 23, 2012 D1BR
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Sep 29, 2011 EXRA
SOU EXTENSION 3 GRANTED
Sep 28, 2011 EX3G
SOU EXTENSION 3 FILED
Sep 22, 2011 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 22, 2011 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Mar 30, 2011 EXRA
SOU EXTENSION 2 GRANTED
Mar 29, 2011 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 28, 2011 AITU
SOU EXTENSION 2 FILED
Mar 17, 2011 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 17, 2011 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Sep 25, 2010 EXRA
SOU EXTENSION 1 GRANTED
Sep 23, 2010 EX1G
SOU EXTENSION 1 FILED
Sep 23, 2010 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 23, 2010 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Mar 23, 2010 NOAM
PUBLISHED FOR OPPOSITION
Dec 29, 2009 PUBO
NOTICE OF PUBLICATION
Dec 9, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 25, 2009 PREV
ASSIGNED TO LIE
Nov 25, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 17, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 10, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 10, 2009 TROA
NON-FINAL ACTION MAILED
May 14, 2009 CNRT
NON-FINAL ACTION WRITTEN
May 14, 2009 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 13, 2009 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 24, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 13, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2009 CRFA
ASSIGNED TO LIE
Apr 9, 2009 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 9, 2009 ERFR
FINAL REFUSAL MAILED
Oct 9, 2008 CNFR
FINAL REFUSAL WRITTEN
Oct 8, 2008 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2008 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 19, 2008 ERSI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2008 TCCA
INQUIRY AS TO SUSPENSION MAILED
Mar 21, 2008 CNSI
SUSPENSION INQUIRY WRITTEN
Mar 21, 2008 CNSI
LETTER OF SUSPENSION MAILED
Sep 21, 2007 CNSL
SUSPENSION LETTER WRITTEN
Sep 21, 2007 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2007 TROA
NON-FINAL ACTION MAILED
Mar 7, 2007 CNRT
NON-FINAL ACTION WRITTEN
Mar 7, 2007 CNRT
ASSIGNED TO EXAMINER
Mar 7, 2007 DOCK
NOTICE OF PSEUDO MARK MAILED
Oct 28, 2006 MPMK
NEW APPLICATION ENTERED
Oct 27, 2006 NWAP